Invasion of the splenic artery is a crucial prognostic factor in carcinoma of the body and tail of the pancreas

Annals of Surgery

Volumn 251, Issue 3, 2010, Pages 483-487

  Kanda, Mitsuro ^a   Fujii, Tsutomu ^a   Sahin, Tevfik T ^a   Kanzaki, Akiyuki ^a   Nagai, Shunji ^a   Yamada, Suguru ^a   Sugimoto, Hiroyuki ^a   Nomoto, Shuji ^a   Takeda, Shin ^a   Kodera, Yasuhiro ^a   Morita, Satoshi ^b   Nakao, Akimasa ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b YOKOHAMA CITY UNIVERSITY MEDICAL CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INVASION; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INVASIVE CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PANCREAS CARCINOMA; PANCREAS RESECTION; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROGNOSIS; SPLEEN ARTERY; SPLENIC VEIN; SURVIVAL RATE; TUMOR VOLUME;

ADENOCARCINOMA; ADULT; AGED; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PANCREATIC NEOPLASMS; PROGNOSIS; RETROSPECTIVE STUDIES; SPLENIC ARTERY; VASCULAR NEOPLASMS;

EID: 77649083160     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e3181cf9171     Document Type: Article

References (29)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2007. CA Cancer J Clin. 2007;57:43-66.
2. Watanabe I, Sasaki S, Konishi M, et al. Onset symptoms and tumor locations as prognostic factors of pancreatic cancer. Pancreas. 2004;28:160-165.
3. Brennan MF, Moccia RD, Klimstra D. Management of adenocarcinoma of the body and tail of the pancreas. Ann Surg. 1996;223:506-512.
4. Shoup M, Conlon KC, Klimstra D, et al. Is extended resection for adenocar-cinoma of the body or tail of the pancreas justified? J Gastrointest Surg. 2003;7:946-952.
5. Nakao A, Takeda S, Sakai M, et al. Extended radical resection versus standard resection for pancreatic cancer: the rationale for extended radical resection. Pancreas. 2004;28:289-292.
6. Reddy SK, Tyler DS, Pappas TN, et al. Extended resection for pancreatic adenocarcinoma. Oncologist. 2007;12:654-663.
7. Nakao A, Fujii T, Sugimoto H, et al. Oncological problems in pancreatic cancer surgery. World J Gastroenterol. 2006;12:4466-4472.
8. Nakao A, Harada A, Nonami T, et al. Clinical significance of carcinoma invasion of the extrapancreatic nerve plexus in pancreatic cancer. Pancreas. 1996;12:357-361.
9. Zacharias T, Jaeck D, Oussoultzoglou E, et al. Impact of lymph node involvement on long-term survival after R0 pancreaticoduodenectomy for ductal adenocarcinoma of the pancreas. J Gastrointest Surg. 2007;11:350-356.
10. Moon HJ, An JY, Heo JS, et al. Predicting survival after surgical resection for pancreatic ductal adenocarcinoma. Pancreas. 2006;32:37-43.
11. Nakao A, Harada A, Nonami T, et al. Lymph node metastasis in carcinoma of the body and tail of the pancreas. Br J Surg. 1997;84:1090-1092.
12. Shimada K, Sakamoto Y, Sano T, et al. Prognostic factors after distal pancreatectomy with extended lymphadenectomy for invasive pancreatic adenocarcinoma of the body and tail. Surgery. 2006;139:288-295.
13. Yamada S, Nakao A, Fujii T, et al. Pancreatic cancer with paraaortic lymph node metastasis: a contraindication for radical surgery? Pancreas. 2009;38: 13-17.
14. Lim JE, Chien MW, Earle CC. Prognostic factors following curative resection for pancreatic adenocarcinoma, a population-based, linked database analysis of 396 patients. Ann Surg. 2003;237:74-85.
15. Yamada S, Takeda S, Fujii T, et al. Clinical implications of peritoneal cytology in potentially resectable pancreatic cancer: positive peritoneal cytology may not confer an adverse prognosis. Ann Surg. 2007;246:254-258.
16. Riediger H, Keck T, Wellner U, et al. The lymph node ratio is the strongest prognostic factor after resection of pancreatic cancer. J Gastrointest Surg. 2009;13:1337-1344.
17. Sakai M, Nakao A, Kaneko T, et al. Para-aortic lymph node metastasis in carcinoma of the head of the pancreas. Surgery. 2005;137:606-611.
18. Japan Pancreatic Society. Classification of Pancreatic Carcinoma. 6th ed. Tokyo, Japan: Kanehara; 2009.
19. International Union Against Cancer. TNM Classification of Malignant Tumours. 5th ed. New York, NY: Wiley-Liss; 1997.
20. International Union Against Cancer. TNM Classification of Malignant Tumours. 6th ed. New York, NY: Wiley-Liss; 2002.
21. Carrère N, Sauvanet A, Goere D, et al. Pancreaticoduodenectomy with mesentericoportal vein resection for adenocarcinoma of the pancreatic head. World J Surg. 2006;30:1526-1535.
22. Schäfer M, Müllhaupt B, Clavien PA. Evidence-based pancreatic head resection for pancreatic cancer and chronic pancreatitis. Ann Surg. 2002;236:137-148.
23. Nakao A, Ichihara T, Nonami T, et al. Clinicohistopathologic and immuno-histochemical studies of intrapancreatic development of carcinoma of the head of the pancreas. Ann Surg. 1989;209:181-187.
24. Fabre JM, Houry S, Manderscheid JC, et al. Surgery for left-sided pancreatic cancer. Br J Surg. 1996;83:1065-1070.
25. Courtney ED, West NJ, Kaur C, et al. Extramural vascular invasion is an adverse prognostic indicator of survival in patients with colorectal cancer. Colorectal Dis. 2009;11:150-156.
26. Pandey D, Lee KH, Wai CT, et al. Long term outcome and prognostic factors for large hepatocellular carcinoma (10 cm or more) after surgical resection. Ann Surg Oncol. 2007;14:2817-2823.
27. Falvo L, Catania A, D'Andrea V, et al. Prognostic importance of histologic vascular invasion in papillary thyroid carcinoma. Ann Surg. 2005;241:640-646.
28. Kooby DA, Suriawinata A, Klimstra DS, et al. Biologic predictors of survival in node-negative gastric cancer. Ann Surg. 2003;237:828-837.
29. Hirano S, Kondo S, Hara T, et al. Distal pancreatectomy with en bloc celiac axis resection for locally advanced pancreatic body cancer: long-term results. Ann Surg. 2007;246:46-51.